Latest Headlines

  1. Blood-Based Test Provides New Diagnostic Approach For Multiple Myeloma 8/8/2025

    Researchers at Dana-Farber Cancer Institute, Massachusetts General Hospital (MGH), and the Broad Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions.

  2. Anbio Biotechnology Responds To Global Outbreaks With Chikungunya Rapid Test And New 15-Minute Ultra-Fast PCR System 8/8/2025

    In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible diagnostic tool at the point of care.

  3. Bringing Advanced Vascular Diagnostics To The Western US With The SmartVascular Dx™ Test 8/8/2025

    MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac Test, is now available in the Western United States.

  4. C2N Announces Major Global Expansion, Adds Six New International Partners 8/7/2025

    C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation, is reaching additional global healthcare providers eager to use its PrecivityAD2 blood test to help diagnose Alzheimer’s disease.

  5. Pleno Inc. Announces First Commercial Agreement With Slopes Bio, Inc 8/6/2025

    Pleno Inc., an early-stage biotechnology company developing innovative multi-omic solutions, and Slopes Bio, Inc., an innovative high-complexity accredited laboratory, today announced a comprehensive commercial agreement in biological target detection and personalized health.

  6. LabConnect Deploys Sapio LIMS Across Global Operations 8/6/2025

    Sapio Sciences, the science-awareTM lab informatics platform, today announced the full deployment of Sapio LIMS at LabConnect.

  7. BioMark Diagnostics Announces Expansion Of Its Specialty Laboratory Services In Quebec To Accommodate Increased Demand From International Partnerships 8/5/2025

    BioMark Diagnostics Inc. a leading developer of liquid biopsy tests for early cancer detection, announces today the completion of a strategic laboratory equipment leasing agreement, substantially doubling BioMark’s testing capacity and positioning the Company for the imminent commercial launch of its lung cancer assay.

  8. Seegene Unveils CURECA™ And STAgora™ At ADLM 2025, Advancing The Next Stage Of Diagnostics 8/5/2025

    Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) designed to advance laboratory automation and data-driven infectious disease monitoring.

  9. Beat Cancer Foundation Partners With OncoSure Testing To Launch Oncosure Advanced Cancer Screening Technology 8/4/2025

    The Beat Cancer Foundation is proud to announce a groundbreaking partnership with OncoSure Testing to bring OncoSure Advanced Cancer Screening Technology to patients nationwide.

  10. Turbine To Simulate Hard-To-Treat Cancer Populations With AI For Identification Of Novel Dependencies Through Collaboration With MSD 8/4/2025

    Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient populations that remain difficult to treat and study in laboratory settings.